Literature DB >> 3265476

Targeted cytotoxic cells as a novel form of cancer immunotherapy.

D M Segal1, M A Garrido, P Perez, J A Titus, D A Winkler, D B Ring, A Kaubisch, J R Wunderlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3265476     DOI： 10.1016/0161-5890(88)90144-7

Source DB:  PubMed          Journal:  Mol Immunol        ISSN： 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  5 in total

Review 1.  Cancer therapy with bispecific antibodies: Clinical experience.

Authors:  Archana Thakur; Lawrence G Lum
Journal:  Curr Opin Mol Ther       Date:  2010-06

2.  Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes.

Authors:  S A Möller; R A Reisfeld
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 3.  Targeting T cells with bispecific antibodies for cancer therapy.

Authors:  Lawrence G Lum; Archana Thakur
Journal:  BioDrugs       Date:  2011-12-01       Impact factor: 5.807

4.  Biodistribution and plasma survival in mice of anti-melanoma monoclonal antibody cross-linked to OKT3.

Authors:  M A Winkler; J O Price; P D Foglesong; W H West
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

Authors:  D R Negri; E Tosi; O Valota; S Ferrini; A Cambiaggi; S Sforzini; A Silvani; P A Ruffini; M I Colnaghi; S Canevari
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.